Pooled literature properties (glycanDB). Optional filters: ?dataset=uv_vis&property_key=...

GET /api/gdd/glyco-properties/?format=api&page=32
HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 839,
    "next": "http://glycodata.org/api/gdd/glyco-properties/?format=api&page=33",
    "previous": "http://glycodata.org/api/gdd/glyco-properties/?format=api&page=31",
    "results": [
        {
            "id": 621,
            "dataset": "heparin",
            "entity": "fondaparinux",
            "entity_group": "",
            "entity_class": "synthetic",
            "property": "anti-Xa activity",
            "property_key": "anti_xa_activity",
            "value": "700",
            "unit": "IU/mg",
            "value_reported": "700",
            "unit_reported": "IU/mg",
            "method": "Review",
            "method_detail": "synthetic pentasaccharide anti-Xa specific activity",
            "conditions": "synthetic pentasaccharide anti-Xa specific activity",
            "conditions_detail": "synthetic pentasaccharide anti-Xa specific activity",
            "doi": "10.1007/s11239-006-5579-4",
            "source_url": "https://doi.org/10.1007/s11239-006-5579-4",
            "year": "2006",
            "confidence": "medium",
            "comments": "\"Fondaparinux is a synthetic pentasaccharide, which binds to antithrombin, thereby indirectly selectively inhibiting factor Xa.\"  — Fondaparinux anti-Xa ~700 IU/mg is widely cited; this source confirms its selective anti-Xa mechanism. Corroborates existing dataset records.  [Bauer KA, 2006, confidence: medium]"
        },
        {
            "id": 622,
            "dataset": "heparin",
            "entity": "heparin",
            "entity_group": "",
            "entity_class": "heparin (UFH)",
            "property": "charge density",
            "property_key": "charge_density",
            "value": "3.7",
            "unit": "per disaccharide",
            "value_reported": "3.7",
            "unit_reported": "per disaccharide",
            "method": "Review",
            "method_detail": "negative charges (sulfo + carboxyl groups) per disaccharide",
            "conditions": "negative charges (sulfo + carboxyl groups) per disaccharide",
            "conditions_detail": "negative charges (sulfo + carboxyl groups) per disaccharide | comparison: vs chondroitin sulfate S/C ~1, dermatan sulfate S/C ~1, DNA/RNA 1 charge per disaccharide",
            "doi": "10.3390/molecules22061025",
            "source_url": "https://doi.org/10.3390/molecules22061025",
            "year": "2017",
            "confidence": "high",
            "comments": "\"Both methods exploit the polymeric nature and uniquely high charge density of heparin (~3.7 negative charges/disaccharide), distinguishing heparin from other biopolymers such as chondroitin sulfate (CS) (S/C ratio of ~1), dermatan sulfate (DS) (S/C ratio of ~1) or DNA/RNA (1 negative charge per disaccharide).\"  — Total negative charges (sulfate + carboxylate) per disaccharide for heparin.  [van der Meer JY, Kellenbach E, van den Bos L, 2017, confidence: high]"
        },
        {
            "id": 623,
            "dataset": "heparin",
            "entity": "heparin",
            "entity_group": "",
            "entity_class": "heparin (UFH)",
            "property": "charge density",
            "property_key": "charge_density",
            "value": "3.3",
            "unit": "per disaccharide",
            "value_reported": "3.3",
            "unit_reported": "per disaccharide",
            "method": "Review",
            "method_detail": "negative charges per disaccharide (highest of any known biomolecule)",
            "conditions": "negative charges per disaccharide (highest of any known biomolecule)",
            "conditions_detail": "negative charges per disaccharide (highest of any known biomolecule)",
            "doi": "10.1039/c7ob01058c",
            "source_url": "https://doi.org/10.1039/c7ob01058c",
            "year": "2017",
            "confidence": "high",
            "comments": "\"Heparin has the highest negative charge density of any known biomolecule (~3.3 negative charges per disaccharide)\"  — Same DOI also has a charge_density=3.3 record in existing dataset; retained here with verbatim quote for the negative-charges-per-disaccharide framing.  [Weiss RJ, Esko JD, Tor Y, 2017, confidence: high]"
        },
        {
            "id": 624,
            "dataset": "heparin",
            "entity": "heparin",
            "entity_group": "",
            "entity_class": "heparin (UFH)",
            "property": "charge density",
            "property_key": "charge_density",
            "value": "2.3",
            "unit": "per disaccharide",
            "value_reported": "2.3",
            "unit_reported": "per disaccharide",
            "method": "Review",
            "method_detail": "sulfate groups per disaccharide (heparin)",
            "conditions": "sulfate groups per disaccharide (heparin)",
            "conditions_detail": "sulfate groups per disaccharide (heparin) | charge type: sulfate groups only (excludes carboxylate)",
            "doi": "10.1039/c7ob01058c",
            "source_url": "https://doi.org/10.1039/c7ob01058c",
            "year": "2017",
            "confidence": "high",
            "comments": "\"heparin is related in structure to HS (2.3 sulfate groups per disaccharide in heparin vs. ~0.8 sulfate groups per disaccharide in typical HS)\"  — Sulfates-per-disaccharide (not total charge); add ~1 carboxylate/disaccharide for total charge.  [Weiss RJ, Esko JD, Tor Y, 2017, confidence: high]"
        },
        {
            "id": 625,
            "dataset": "heparin",
            "entity": "heparan sulfate (typical)",
            "entity_group": "",
            "entity_class": "heparan sulfate",
            "property": "charge density",
            "property_key": "charge_density",
            "value": "0.8",
            "unit": "per disaccharide",
            "value_reported": "0.8",
            "unit_reported": "per disaccharide",
            "method": "Review",
            "method_detail": "sulfate groups per disaccharide (typical heparan sulfate)",
            "conditions": "sulfate groups per disaccharide (typical heparan sulfate)",
            "conditions_detail": "sulfate groups per disaccharide (typical heparan sulfate) | charge type: sulfate groups only (excludes carboxylate)",
            "doi": "10.1039/c7ob01058c",
            "source_url": "https://doi.org/10.1039/c7ob01058c",
            "year": "2017",
            "confidence": "high",
            "comments": "\"2.3 sulfate groups per disaccharide in heparin vs. ~0.8 sulfate groups per disaccharide in typical HS\"  — Heparan sulfate sulfates-per-disaccharide (much lower than heparin).  [Weiss RJ, Esko JD, Tor Y, 2017, confidence: high]"
        },
        {
            "id": 626,
            "dataset": "heparin",
            "entity": "heparin",
            "entity_group": "",
            "entity_class": "heparin (UFH)",
            "property": "charge density",
            "property_key": "charge_density",
            "value": "2.5",
            "unit": "per disaccharide",
            "value_reported": "2.5",
            "unit_reported": "per disaccharide",
            "method": "Experiment",
            "method_detail": "average sulfation level (sulfates per disaccharide) from disaccharide composition analysis; ~2.2 measured for porcine mucosal heparin",
            "conditions": "average sulfation level (sulfates per disaccharide) from disaccharide composition analysis; ~2.2 measured for porcine mucosal heparin",
            "conditions_detail": "average sulfation level (sulfates per disaccharide) from disaccharide composition analysis; ~2.2 measured for porcine mucosal heparin | range: 1.4-2.5 sulfates per disaccharide (typically high end) | measured PMH: 2.2 | charge type: sulfate groups only",
            "doi": "10.1038/s41598-019-39093-6",
            "source_url": "https://doi.org/10.1038/s41598-019-39093-6",
            "year": "2019",
            "confidence": "high",
            "comments": "\"This provides Hp with an overall sulfation level of 1.4-2.5 sulfates per disaccharide unit, but most typically at the higher end of this range\"  — Heparin overall sulfation (sulfates per disaccharide); same paper measured ~2.2 for porcine mucosal heparin.  [Taylor S, Hogwood J, Guo W, et al., 2019, confidence: high]"
        },
        {
            "id": 627,
            "dataset": "heparin",
            "entity": "heparan sulfate",
            "entity_group": "",
            "entity_class": "heparan sulfate",
            "property": "charge density",
            "property_key": "charge_density",
            "value": "0.9",
            "unit": "per disaccharide",
            "value_reported": "0.55-1.25",
            "unit_reported": "per disaccharide",
            "method": "Review",
            "method_detail": "typical overall sulfation (sulfates per disaccharide) of heparan sulfate",
            "conditions": "typical overall sulfation (sulfates per disaccharide) of heparan sulfate",
            "conditions_detail": "typical overall sulfation (sulfates per disaccharide) of heparan sulfate | charge type: sulfate groups only (excludes carboxylate)",
            "doi": "10.1038/s41598-019-39093-6",
            "source_url": "https://doi.org/10.1038/s41598-019-39093-6",
            "year": "2019",
            "confidence": "high",
            "comments": "\"HS ... usually comprises much longer chains. HS possesses higher ratios of GlcA/IdoA and GlcNAc/GlcNS compared to Hp, and lower overall sulfation (typically 0.55-1.25 sulfates per disaccharide).\"  — Heparan sulfate overall sulfation range.  [Taylor S, Hogwood J, Guo W, et al., 2019, confidence: high]"
        },
        {
            "id": 628,
            "dataset": "heparin",
            "entity": "heparan sulfate (mouse kidney cortex)",
            "entity_group": "",
            "entity_class": "heparan sulfate",
            "property": "charge density",
            "property_key": "charge_density",
            "value": "0.79",
            "unit": "per disaccharide",
            "value_reported": "0.79",
            "unit_reported": "per disaccharide",
            "method": "Experiment",
            "method_detail": "sulfate per disaccharide by RPIP-HPLC disaccharide analysis of HS from db/+ control mouse kidney",
            "conditions": "sulfate per disaccharide by RPIP-HPLC disaccharide analysis of HS from db/+ control mouse kidney",
            "conditions_detail": "sulfate per disaccharide by RPIP-HPLC disaccharide analysis of HS from db/+ control mouse kidney | tissue: mouse kidney cortex (db/+ control) | uncertainty: +/-0.10 SEM | charge type: sulfate groups only",
            "doi": "10.1369/0022155413494392",
            "source_url": "https://doi.org/10.1369/0022155413494392",
            "year": "2013",
            "confidence": "high",
            "comments": "\"The amount (mean +/- SEM) of sulfate per disaccharide unit was 0.90 +/- 0.03 for HS from db/db mice and 0.79 +/- 0.10 for HS from db/+ mice\"  — Experimentally measured HS sulfate-per-disaccharide (control kidney).  [Reine TM, Grondahl F, Jenssen T, et al., 2013, confidence: high]"
        },
        {
            "id": 629,
            "dataset": "heparin",
            "entity": "heparan sulfate (mouse kidney cortex, diabetic db/db)",
            "entity_group": "",
            "entity_class": "heparan sulfate",
            "property": "charge density",
            "property_key": "charge_density",
            "value": "0.9",
            "unit": "per disaccharide",
            "value_reported": "0.9",
            "unit_reported": "per disaccharide",
            "method": "Experiment",
            "method_detail": "sulfate per disaccharide by RPIP-HPLC disaccharide analysis of HS from db/db diabetic mouse kidney",
            "conditions": "sulfate per disaccharide by RPIP-HPLC disaccharide analysis of HS from db/db diabetic mouse kidney",
            "conditions_detail": "sulfate per disaccharide by RPIP-HPLC disaccharide analysis of HS from db/db diabetic mouse kidney | tissue: mouse kidney cortex (db/db diabetic) | uncertainty: +/-0.03 SEM | charge type: sulfate groups only",
            "doi": "10.1369/0022155413494392",
            "source_url": "https://doi.org/10.1369/0022155413494392",
            "year": "2013",
            "confidence": "high",
            "comments": "\"The amount (mean +/- SEM) of sulfate per disaccharide unit was 0.90 +/- 0.03 for HS from db/db mice and 0.79 +/- 0.10 for HS from db/+ mice\"  — Experimentally measured HS sulfate-per-disaccharide (diabetic kidney); no significant difference vs control.  [Reine TM, Grondahl F, Jenssen T, et al., 2013, confidence: high]"
        },
        {
            "id": 630,
            "dataset": "heparin",
            "entity": "heparin (Anodonta anodonta, slow-moving high-MW component)",
            "entity_group": "",
            "entity_class": "heparinoid (other)",
            "property": "charge density",
            "property_key": "charge_density",
            "value": "2.66",
            "unit": "per disaccharide",
            "value_reported": "2.66",
            "unit_reported": "per disaccharide",
            "method": "Experiment",
            "method_detail": "sulfate-to-carboxyl (S/C) ratio of the high-MW heparin component from freshwater mollusc, by oligosaccharide mapping",
            "conditions": "sulfate-to-carboxyl (S/C) ratio of the high-MW heparin component from freshwater mollusc, by oligosaccharide mapping",
            "conditions_detail": "sulfate-to-carboxyl (S/C) ratio of the high-MW heparin component from freshwater mollusc, by oligosaccharide mapping | source species: Anodonta anodonta (freshwater mollusc) | Mr: 14900 | metric: sulfate-to-carboxyl ratio",
            "doi": "10.1021/bm0505033",
            "source_url": "https://doi.org/10.1021/bm0505033",
            "year": "2005",
            "confidence": "high",
            "comments": "\"The first species had an Mr of about 14 900 and a sulfate-to-carboxyl ratio of 2.66, while the second heparin component had an Mr of 7920 and a charge density of 2.11.\"  — Mollusc-derived heparin; S/C ratio (sulfates per carboxyl ~= sulfates per disaccharide since 1 carboxyl/disaccharide).  [Volpi N, Maccari F, 2005, confidence: high]"
        },
        {
            "id": 631,
            "dataset": "heparin",
            "entity": "heparin (Anodonta anodonta, fast-moving low-MW component)",
            "entity_group": "",
            "entity_class": "heparinoid (other)",
            "property": "charge density",
            "property_key": "charge_density",
            "value": "2.11",
            "unit": "per disaccharide",
            "value_reported": "2.11",
            "unit_reported": "per disaccharide",
            "method": "Experiment",
            "method_detail": "charge density (sulfate per disaccharide) of the low-MW heparin component from freshwater mollusc",
            "conditions": "charge density (sulfate per disaccharide) of the low-MW heparin component from freshwater mollusc",
            "conditions_detail": "charge density (sulfate per disaccharide) of the low-MW heparin component from freshwater mollusc | source species: Anodonta anodonta (freshwater mollusc) | Mr: 7920 | metric: charge density (S per disaccharide)",
            "doi": "10.1021/bm0505033",
            "source_url": "https://doi.org/10.1021/bm0505033",
            "year": "2005",
            "confidence": "high",
            "comments": "\"the second heparin component had an Mr of 7920 and a charge density of 2.11.\"  — Lower-sulfated mollusc heparin component.  [Volpi N, Maccari F, 2005, confidence: high]"
        },
        {
            "id": 632,
            "dataset": "heparin",
            "entity": "heparin (free acid, amorphous preparations)",
            "entity_group": "",
            "entity_class": "heparin (UFH)",
            "property": "sulfur content",
            "property_key": "sulfur_content",
            "value": "13.5",
            "unit": "% sulfur",
            "value_reported": "13.5",
            "unit_reported": "% sulfur",
            "method": "Experiment",
            "method_detail": "elemental sulphur analysis of amorphous heparin free acid (classic fractionation study)",
            "conditions": "elemental sulphur analysis of amorphous heparin free acid (classic fractionation study)",
            "conditions_detail": "elemental sulphur analysis of amorphous heparin free acid (classic fractionation study) | form: free acid, amorphous | basis: % S by mass | qualifier: up to",
            "doi": "10.1042/bj0330047",
            "source_url": "https://doi.org/10.1042/bj0330047",
            "year": "1939",
            "confidence": "high",
            "comments": "\"the amorphous preparations can contain 20 % more S (up to 13.5 % in the free acid) than the crystalline product, which has 11.5 %.\"  — Highest %S for amorphous heparin free acid (classic elemental-analysis paper).  [Jorpes E, Bergstrom S, 1939, confidence: high]"
        },
        {
            "id": 633,
            "dataset": "heparin",
            "entity": "heparin (crystalline barium salt-derived free acid)",
            "entity_group": "",
            "entity_class": "heparin (UFH)",
            "property": "sulfur content",
            "property_key": "sulfur_content",
            "value": "11.5",
            "unit": "% sulfur",
            "value_reported": "11.5",
            "unit_reported": "% sulfur",
            "method": "Experiment",
            "method_detail": "elemental sulphur analysis of crystalline heparin product (free acid)",
            "conditions": "elemental sulphur analysis of crystalline heparin product (free acid)",
            "conditions_detail": "elemental sulphur analysis of crystalline heparin product (free acid) | form: crystalline product, free acid | basis: % S by mass",
            "doi": "10.1042/bj0330047",
            "source_url": "https://doi.org/10.1042/bj0330047",
            "year": "1939",
            "confidence": "high",
            "comments": "\"the amorphous preparations can contain 20 % more S (up to 13.5 % in the free acid) than the crystalline product, which has 11.5 %.\"  — %S of crystalline heparin product.  [Jorpes E, Bergstrom S, 1939, confidence: high]"
        },
        {
            "id": 634,
            "dataset": "heparin",
            "entity": "heparin (liver, fractionated preparations)",
            "entity_group": "",
            "entity_class": "heparin (UFH)",
            "property": "sulfur content",
            "property_key": "sulfur_content",
            "value": "9.629999999999999",
            "unit": "% sulfur",
            "value_reported": "7-12.26",
            "unit_reported": "% sulfur",
            "method": "Experiment",
            "method_detail": "elemental sulphur analysis range across liver heparin fractions, correlated with anticoagulant potency",
            "conditions": "elemental sulphur analysis range across liver heparin fractions, correlated with anticoagulant potency",
            "conditions_detail": "elemental sulphur analysis range across liver heparin fractions, correlated with anticoagulant potency | source: liver | basis: % S by mass | potency range: 45-160% of standard",
            "doi": "10.1042/bj0330047",
            "source_url": "https://doi.org/10.1042/bj0330047",
            "year": "1939",
            "confidence": "high",
            "comments": "\"Preparations of liver heparin containing from 7 to 12 26 % S show potencies varying from 45 to 160 % of the activity of the standard heparin from which they are derived.\"  — Liver heparin %S range; '12 26' in OCR is 12.26%. Anticoagulant potency rises with sulfur content.  [Jorpes E, Bergstrom S, 1939, confidence: high]"
        },
        {
            "id": 635,
            "dataset": "heparin",
            "entity": "supersulfated heparin (depolymerized)",
            "entity_group": "",
            "entity_class": "heparinoid (other)",
            "property": "sulfur content",
            "property_key": "sulfur_content",
            "value": "13.56",
            "unit": "% sulfur",
            "value_reported": "13.56",
            "unit_reported": "% sulfur",
            "method": "Experiment",
            "method_detail": "elemental analysis (sodium salt) of depolymerized and supersulfated heparin",
            "conditions": "elemental analysis (sodium salt) of depolymerized and supersulfated heparin",
            "conditions_detail": "elemental analysis (sodium salt) of depolymerized and supersulfated heparin | form: sodium salt | modification: depolymerized + supersulfated | basis: % S by mass",
            "doi": "",
            "source_url": "https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4727063",
            "year": "1988",
            "confidence": "medium",
            "comments": "\"depolymerized and supersulfated sodium heparin ... elemental analysis showing S: 13.56%\"  — Patent elemental analysis of a supersulfated heparin (no DOI; US patent). Higher than native heparin due to extra sulfation.  [US Patent 4727063, 1988, confidence: medium]"
        },
        {
            "id": 636,
            "dataset": "heparin",
            "entity": "heparin pentasaccharide (fondaparinux)",
            "entity_group": "",
            "entity_class": "synthetic",
            "property": "protein binding affinity (Kd)",
            "property_key": "binding_affinity",
            "value": "0.022",
            "unit": "µM",
            "value_reported": "22.0",
            "unit_reported": "nM",
            "method": "Experiment",
            "method_detail": "Kd vs antithrombin (AT), measured by enhancement of AT intrinsic fluorescence (ex 280 nm, em 340 nm) on fondaparinux binding",
            "conditions": "Kd vs antithrombin (AT), measured by enhancement of AT intrinsic fluorescence (ex 280 nm, em 340 nm) on fondaparinux binding",
            "conditions_detail": "Kd vs antithrombin (AT), measured by enhancement of AT intrinsic fluorescence (ex 280 nm, em 340 nm) on fondaparinux binding | partner: antithrombin III | technique: fluorescence | temperature C: 25",
            "doi": "10.1074/jbc.M113.485268",
            "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3764794/",
            "year": "2013",
            "confidence": "high",
            "comments": "\"Fondaparinux bound to antithrombin with a KD of 22.0 ± 3.4 nM\"  — Synthetic AT-binding pentasaccharide (fondaparinux); canonical AT-III interaction  [Viskov C, Just M, Laux V, Mourier P, Lorenz M, et al., 2013, confidence: high]"
        },
        {
            "id": 637,
            "dataset": "heparin",
            "entity": "heparin pentasaccharide (fondaparinux)",
            "entity_group": "",
            "entity_class": "synthetic",
            "property": "protein binding affinity (Kd)",
            "property_key": "binding_affinity",
            "value": "0.0207",
            "unit": "µM",
            "value_reported": "0.0207",
            "unit_reported": "µM",
            "method": "Experiment",
            "method_detail": "Kd vs antithrombin (AT) by fluorescence titration at 0.1 M NaCl",
            "conditions": "Kd vs antithrombin (AT) by fluorescence titration at 0.1 M NaCl",
            "conditions_detail": "Kd vs antithrombin (AT) by fluorescence titration at 0.1 M NaCl | partner: antithrombin III | technique: fluorescence | NaCl M: 0.1 | temperature C: 25",
            "doi": "10.1074/jbc.M113.485268",
            "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3764794/",
            "year": "2013",
            "confidence": "high",
            "comments": "\"The Kd values obtained for fondaparinux ... 0.0207 µM at 0.1 M NaCl\"  — Fondaparinux/AT Kd at low salt; Table 3  [Viskov C, Just M, Laux V, Mourier P, Lorenz M, et al., 2013, confidence: high]"
        },
        {
            "id": 638,
            "dataset": "heparin",
            "entity": "heparin pentasaccharide (fondaparinux)",
            "entity_group": "",
            "entity_class": "synthetic",
            "property": "protein binding affinity (Kd)",
            "property_key": "binding_affinity",
            "value": "0.279",
            "unit": "µM",
            "value_reported": "0.279",
            "unit_reported": "µM",
            "method": "Experiment",
            "method_detail": "Kd vs antithrombin (AT) by fluorescence titration at 0.25 M NaCl",
            "conditions": "Kd vs antithrombin (AT) by fluorescence titration at 0.25 M NaCl",
            "conditions_detail": "Kd vs antithrombin (AT) by fluorescence titration at 0.25 M NaCl | partner: antithrombin III | technique: fluorescence | NaCl M: 0.25 | temperature C: 25",
            "doi": "10.1074/jbc.M113.485268",
            "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3764794/",
            "year": "2013",
            "confidence": "high",
            "comments": "\"Kd values obtained for fondaparinux ... 0.279 µM at 0.25 M NaCl\"  — Fondaparinux/AT Kd at physiological salt; Table 3. Ionic strength markedly weakens affinity  [Viskov C, Just M, Laux V, Mourier P, Lorenz M, et al., 2013, confidence: high]"
        },
        {
            "id": 639,
            "dataset": "heparin",
            "entity": "heparin pentasaccharide (fondaparinux)",
            "entity_group": "",
            "entity_class": "synthetic",
            "property": "protein binding affinity (Kd)",
            "property_key": "binding_affinity",
            "value": "3.47",
            "unit": "µM",
            "value_reported": "3.47",
            "unit_reported": "µM",
            "method": "Experiment",
            "method_detail": "Kd vs antithrombin (AT) by fluorescence titration at 0.5 M NaCl",
            "conditions": "Kd vs antithrombin (AT) by fluorescence titration at 0.5 M NaCl",
            "conditions_detail": "Kd vs antithrombin (AT) by fluorescence titration at 0.5 M NaCl | partner: antithrombin III | technique: fluorescence | NaCl M: 0.5 | temperature C: 25",
            "doi": "10.1074/jbc.M113.485268",
            "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3764794/",
            "year": "2013",
            "confidence": "high",
            "comments": "\"Kd values obtained for fondaparinux ... 3.47 µM at 0.5 M NaCl\"  — Fondaparinux/AT Kd at high salt; Table 3  [Viskov C, Just M, Laux V, Mourier P, Lorenz M, et al., 2013, confidence: high]"
        },
        {
            "id": 640,
            "dataset": "heparin",
            "entity": "heparin dodecasaccharide (two AT-binding pentasaccharides)",
            "entity_group": "",
            "entity_class": "heparin oligosaccharide",
            "property": "protein binding affinity (Kd)",
            "property_key": "binding_affinity",
            "value": "0.0099",
            "unit": "µM",
            "value_reported": "0.0099",
            "unit_reported": "µM",
            "method": "Experiment",
            "method_detail": "Kd vs antithrombin (AT) by fluorescence titration at 0.1 M NaCl",
            "conditions": "Kd vs antithrombin (AT) by fluorescence titration at 0.1 M NaCl",
            "conditions_detail": "Kd vs antithrombin (AT) by fluorescence titration at 0.1 M NaCl | partner: antithrombin III | technique: fluorescence | NaCl M: 0.1 | temperature C: 25",
            "doi": "10.1074/jbc.M113.485268",
            "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3764794/",
            "year": "2013",
            "confidence": "high",
            "comments": "\"Binding of the dodecasaccharide to AT was investigated in the presence of 0.1, 0.25, and 0.5 M NaCl yielding Kd values of 0.0099, 0.086, and 1.23 µM, respectively\"  — Dodecasaccharide with two pentasaccharide motifs; 0.1 M NaCl  [Viskov C, Just M, Laux V, Mourier P, Lorenz M, et al., 2013, confidence: high]"
        }
    ]
}